The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13 - PubMed (original) (raw)
. 1993 Sep 15;151(6):2915-27.
Affiliations
- PMID: 7690791
The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13
L E Bradbury et al. J Immunol. 1993.
Abstract
CD19 expressed on the surface of B lymphocytes is a key member of a cell surface signal transduction complex that includes TAPA-1, Leu 13 and CD21. The human CD19 protein is composed of 540 amino acids with a cytoplasmic domain of 242 amino acids. Although the cytoplasmic domain of CD19 has no sequence homology with other proteins, the cytoplasmic domain of human, mouse, and guinea pig CD19 is highly conserved suggesting that this region of CD19 is at least partially responsible for signaling activity. In this study, the regions of CD19 required for intermolecular associations and signal transduction were determined by comparing a series of carboxyl-terminal cytoplasmic tail deletion mutants and a CD19/L-selectin chimera with native CD19. CD19 expressed in the human Rex T cell line and the K562 erythroleukemia cell line generated transmembrane signals and also associated with endogenous TAPA-1. Deletion of 95% of the CD19 cytoplasmic domain did not affect the ability of CD19 to be expressed or to associate with TAPA-1. However, replacement of the CD19 transmembrane and cytoplasmic domains with those of L-selectin (CD19-LAM) resulted in the loss of CD19 complex formation, suggesting that the membrane spanning domain is critical for this association. Similarly, the induction of homotypic adhesion through CD19 or truncated CD19 was equivalent, whereas homotypic adhesion was not induced via the CD19-LAM chimera. In addition, the cytoplasmic domain was not necessary for CD19 mAb-mediated growth inhibition or internalization. In contrast, the CD19 cytoplasmic domain was required for optimal mAb-induced increases in [Ca2+]i in CD19 cDNA-transfected Rex cells. Thus, the CD19 cytoplasmic domain is responsible for the induction of increased [Ca2+]i, and the transmembrane region is required for cell surface associations with the other members of the CD19 complex and most signaling events. Therefore, mAb binding to CD19 is likely to initiate multiple intracellular signal transduction cascades either through CD19 directly, or through other members of the CD19 complex.
Similar articles
- The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF. Bradbury LE, et al. J Immunol. 1992 Nov 1;149(9):2841-50. J Immunol. 1992. PMID: 1383329 - The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
Fearon DT, Carter RH. Fearon DT, et al. Annu Rev Immunol. 1995;13:127-49. doi: 10.1146/annurev.iy.13.040195.001015. Annu Rev Immunol. 1995. PMID: 7542009 Review. - The CD19/CD21 signal transduction complex of B lymphocytes.
Tedder TF, Zhou LJ, Engel P. Tedder TF, et al. Immunol Today. 1994 Sep;15(9):437-42. doi: 10.1016/0167-5699(94)90274-7. Immunol Today. 1994. PMID: 7524521 Review.
Cited by
- The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
Gorman MJ, Poddar S, Farzan M, Diamond MS. Gorman MJ, et al. J Virol. 2016 Aug 26;90(18):8212-25. doi: 10.1128/JVI.00581-16. Print 2016 Sep 15. J Virol. 2016. PMID: 27384652 Free PMC article. - Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.
Peddibhotla SS, Brinkmann BF, Kummer D, Tuncay H, Nakayama M, Adams RH, Gerke V, Ebnet K. Peddibhotla SS, et al. Mol Biol Cell. 2013 Apr;24(7):933-44. doi: 10.1091/mbc.E12-06-0481. Epub 2013 Feb 6. Mol Biol Cell. 2013. PMID: 23389628 Free PMC article. - A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L, Hewitt FB, Willis VC, Rodriguez R, Tomlinson S, Holers VM. Kulik L, et al. Mol Immunol. 2015 Feb;63(2):479-88. doi: 10.1016/j.molimm.2014.10.005. Mol Immunol. 2015. PMID: 25457881 Free PMC article. - Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.
Twohig J, Kulik L, Haluszczak C, Reuter J, Rossbach A, Bull M, Holers VM, Marchbank KJ. Twohig J, et al. Mol Immunol. 2007 Jul;44(13):3434-44. doi: 10.1016/j.molimm.2007.02.011. Epub 2007 Mar 26. Mol Immunol. 2007. PMID: 17379312 Free PMC article. - Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.
Tsitsikov EN, Gutierrez-Ramos JC, Geha RS. Tsitsikov EN, et al. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10844-9. doi: 10.1073/pnas.94.20.10844. Proc Natl Acad Sci U S A. 1997. PMID: 9380722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous